Researchers at the University of Guelph have unlocked the procedure of manufacturing two discomfort-relieving molecules in cannabis that are stated to be almost 30 occasions additional potent than aspirin.

The study, published in the August 2019 volume of Phytochemistry, had professors Tariq Akhtar and Steven Rothstein use biochemistry and genomics to figure out how cannabis tends to make the molecules referred to as cannflavin A and cannflavin B.

Identified as ‘flavonoids,’ cannflavins A and B had been 1st identified in 1985, “when analysis verified they offered anti-inflammatory rewards that had been almost 30 occasions additional effective…than aspirin” the university stated in a press release.

– Study the whole report at CTV News.